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Abstract
This is an editorial report of the supplement to BMC Genomics that includes 15 papers selected from the
BIOCOMP’10 - The 2010 International Conference on Bioinformatics & Computational Biology as well as other
sources with a focus on genomics studies.
BIOCOMP’10 was held on July 12-15 in Las Vegas, Nevada. The congress covered a large variety of research areas,
and genomics was one of the major focuses because of the fast development in this field. We set out to launch a
supplement to BMC Genomics with manuscripts selected from this congress and invited submissions. With a
rigorous peer review process, we selected 15 manuscripts that showed work in cutting-edge genomics fields and
proposed innovative methodology. We hope this supplement presents the current computational and statistical
challenges faced in genomics studies, and shows the enormous promises and opportunities in the genomic future.
Although the high throughput technology has made
continuous progress during the last decade in terms of
size, cost and signal quality, it remains challenging to
deduce reliable predictive signatures from genomic data
due to a small sample size and a large number of vari-
ables. Much effort of this supplement is devoted to
developing predictive models for various types of geno-
mic data, including mRNA, microRNA, and genome
DNA. One of the important applications for RNA
microarray data is to identify differentially expressed
genes that can lead to gene signatures for predicting dis-
ease status and drug response. Mao et al. [1] investi-
gated the differential gene expression between African
Americans and Caucasians in white blood cells expres-
sion profiles for both type 2 diabetes patients and
healthy people. The newly identified gene markers
implicate the genetic basis for distinct risks of type 2
diabetes between these two populations. For microarray
data, Due to the high cost of GeneChip, microarray
experiments often have low sample sizes that present
challenging for statistical analysis. In view of the difficul-
ties for applying the common-used microarray analysis
methods such as t-test, SAM, and FDR for small sample
size experiment, Chen and his colleagues [2] proposed a
model-based information sharing method (MBIS) that
enhances the power of statistical test by utilizing infor-
mation shared among genes. Next-generation sequen-
cing technology enables the quantification of gene
expression in the species whose gene chips are not avail-
able in market. Chen and his colleagues [3] used the 454
pyrosequencing technology to perform the transcrip-
tome sequencing for an important herb medicine, the
root of Panax notoginseng. This work discovered more
than 20K unique transcripts and around 900 putative
transcription factors.
When using gene signature for classification of disease
phenotypes, it is critical to determine a subset of genes
that is reliable across various studies and that provides
high predictive power for the disease status. Liu et al.
[4] have developed a gene selection algorithm, Recursive
Feature Addition, that combines supervised learning
method and statistical similarity measures. The gene
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signature was further optimized via a novel algorithm,
Lagging Prediction Peephole Optimization. On the other
hand, Shi and his colleagues [5] aimed to minimize the
number of genes in a gene signature while maintaining
its predictive power. They proposed a method called
Minimize Feature’s Size that makes use of similarity
analyses between different endpoints and at multiple
levels such as probe, gene, and GO. Both manuscripts
validated their methods by comparing with various gene
signature algorithms using benchmark microarray data.
The advocacy of personalized medicine in complicated
diseases such as cancer and neural defects has made it
increasingly important to identify genomic signatures
that are associated with clinical outcomes. Several
manuscripts of this supplement address questions in
this aspect using various types of data. Zhao et al. [6]
investigated a number of models for predicating cancer
overall survival using gene expression profile from
microarray data and found that the maximum predictive
power of each model is limited by the correlation
between endpoint and gene expression. Instead of look-
ing at mRNA expression level, Zhang and his colleagues
[7] focused on identifying DNA copy number variation
that is correlated with cancer over survival. They devel-
oped a novel and efficient algorithm using a hidden
Markov model to take into account the correlation
between markers in SNP array. The algorithm classified
glioma samples with distinct overall survival time. In the
manuscript by Wang and his colleagues [8], they moved
further to associate single nucleotide variations with sin-
gle amino acid polymorphisms (SAPs) that can be used
for predicting disease risk. They have validated their
results using public datasets such as 1000 Genome Pro-
ject and Genetic Analysis Workshop (GAW17). Protein-
protein interaction (PPI) networks Protein functions
were utilized by Huang and Chen [9] to predict drug
cardiotoxicity. They proposed a systems biology frame-
work to predict adverse drug reactions (ADR) using
supervised learning methods such as support vector
machine. This framework has a potential large impact to
pharmaceutical industry for ADR is one of the major
reasons for drug withdrawals in clinical trials.
Nowadays researchers are interested in not only what
individual genes are activated, but also how genes inter-
act with each other. Modelling gene networking presents
a high challenge for bioinformatics because of incomplete
information of gene functions and gene-gene interac-
tions. About half of the manuscripts in this supplement
are addressing questions regarding gene networking. Li et
al. [10] developed a modified version of dynamic Baye-
sian Network for time-series microarray data, and
showed that the proposed method provided an enhanced
accuracy for predicting gene regulatory network struc-
ture. Wang and his colleagues [11] applied network
analysis to protein-protein interaction data from the
STRING database and identified a number of proteins
that are associated with proteases Malaria parasite. These
results illustrated the diverse functions of protease and
implicated novel targets of drug design for Malaria.
DNA- or RNA-binding proteins play a critical role in
gene regulatory networking. Liu and his colleagues [12]
integrated the RNA sequence and secondary structures to
to identify the consensus sequence of protein-RNA bind-
ing sites. This novel model-based approach, called RNA-
MotifModeler, demonstrated a number of statistical
advantages when being applied to the RNA-binding pro-
tein SRSF1. The effect of epigenetic modification on gene
regulation has been widely investigated. In this supple-
ment, a manuscript by Zhao and his colleagues [13]
looked into the combined regulation of epigenetic modifi-
cation and miRNA in mediating gene networking. They
conducted a genome-wide study and showed that DNA
methylation and miRNA function are complementary to
each other for gene regulation. This finding would
advance our predictive models for gene regulatory net-
works by incorporating the epigenetic and miRNA factors.
Some of the authors devoted their efforts to tradi-
tional bioinformatics areas. Many alignment algorithm
for DNA or protein sequences were proposed in 1980s,
nonetheless, multiple sequence alignment is still a
challenging question because of its computing inten-
sity, which manifests with the advancement of the
next-generation sequencing. Nguyen, Pan and Nong
[14] provided a solution for multiple sequence align-
ment by combining the pair-wise dynamic program-
ming algorithm with parallel computing approach
using R-Mesh. This new method achieved computing
time at O(m), where m is the number of sequences.
Bio-imaging analysis is another active field of bioinfor-
matics. Tang and his colleagues [15] proposed a robust
method to reduce the specles that present obstacles for
ultrasound image post-processing. They used a detail
preserving anisotropic diffusion filter and showed that
their method prohibit over-diffusion and preserved the
important structure information.
We are proud of the high quality of the manuscripts
contained within this issue. We hope they would guide
current genomics research and indicate the trend for
future study.
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